Feedback / Questions
berubicin (RTA 744) - CNS Pharma, WPD Pharma
https://www.globenewswire.com/news-release/2021/10/11/2311765/0/en/CNS-Pharmaceuticals-Inc-Featured-in-Syndicated-Broadcast-Covering-Dosing-of-First-Patients-in-Its-Berubicin-Clinical-Development-Program-for-Glioblastoma-Multiforme.html
Oct 11, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next